Lunatus and ORTHOREBIRTH Enter Exclusive Agency Agreement for ReBOSSIS Across the Middle East

Lunatus and ORTHOREBIRTH Enter Exclusive Agency Agreement for ReBOSSIS Across the Middle East

Lunatus and ORTHOREBIRTH Enter Exclusive Agency Agreement for ReBOSSIS Across the Middle East   Dubai, UAE – Lunatus Marketing & Consulting FZCO (“Lunatus”) has signed an exclusive agency agreement with ORTHOREBIRTH Co., Ltd., a Japan-based medical device company headquartered in Yokohama, to commercialize ReBOSSIS across the Middle East. The agreement covers Saudi Arabia, United Arab […]

Lunatus and KYORIN Enter Exclusive Agency Agreement for Lasvic® Tablets Across the Middle East

Dubai, United Arab Emirates — January 5, 2026   Lunatus and KYORIN Enter Exclusive Agency Agreement for Lasvic® Tablets Across the Middle East   Lunatus Marketing & Consulting FZCO, a leading turnkey partner for pharmaceutical and healthcare companies in the Middle East, today announced the signing of an exclusive agency agreement with KYORIN Pharmaceutical Co., […]

Lunatus and Hartington Pharmaceutical Sign Exclusive Agency Agreement for NASODREN® Nasal Spray Across the Middle East

Lunatus and Hartington Pharmaceutical Sign Exclusive Agency Agreement for NASODREN® Nasal Spray Across the Middle East Lunatus Marketing and Consulting FZCO, a leading turnkey partner for pharmaceutical and healthcare companies in the Middle East, today announced the signing of an exclusive agency agreement with Hartington Pharmaceutical SLU to commercialize NASODREN® Nasal Spray across nine territories […]

Lunatus and LENZ Therapeutics Announce Exclusive Commercialization Partnership for VIZZTM in the Middle East

Lunatus and LENZ Therapeutics Announce Exclusive Commercialization Partnership for VIZZTM in the Middle East Dubai, United Arab Emirates and SAN DIEGO, CA– January 5, 2026 –Lunatus Marketing & Consulting FZCO (“Lunatus”) and LENZ Therapeutics, Inc. (“LENZ”) today announced an exclusive partnership agreement for Lunatus to register and commercialize VIZZTM for the treatment of presbyopia in […]

Lunatus and AFYX Therapeutics A/S Announce Distribution and Sales Collaboration

Hørsholm, Denmark – April 23, 2025 Lunatus and AFYX Therapeutics A/S are pleased to announce a new distribution and sales collaboration for AFYX’s induction of labor product, Gefena (Misoprostol 25μg tablet). Under this agreement, Lunatus will distribute, commercialize and supply Gefena in the following countries: United Arab Emirates, Qatar, Kuwait, Oman, Kingdom of Saudi Arabia, Bahrain, […]

In partnership with Lunatus, IBSA Group strengthens its presence in the Middle East

Thanks to a new one strategic partnership with the distributor Lunatus, IBSA has expanded its presence in the osteoarticular area in Saudi Arabia and the United Arab Emirates, with the aim of offering advanced treatments for the management of pain and related conditions. In the coming years, this collaboration may also extend to other countries in the region, to […]

Lunatus & Marubeni Partnership

Lunatus Marketing & Consulting FZCO Marubeni Corporation The fast-growing Middle East healthcare industry, driven by the increase of healthcare related expenditures from both the public and private sectors, fuels the interest of international companies looking to invest in this growing sector in Middle East in general and the UAE in particular. Marubeni Corporation (hereinafter, “Marubeni”) […]